Agrifood giant Archer Daniels Midland has announced it is to increase production of its NovaLipid line of zero/low trans-fat oils and margarines, by adding capacity at its Mankato, Minnesota enzyme interesterification facility.

Construction is scheduled to be completed late in 2005, it said. This is the second expansion to the NovaLipid line. Last year, the Company had announced that it was expanding its production at its Quincy, Illinois facility to help satisfy the food industry’s demand as it moves forward to meet the 1 January 2006, FDA labelling requirement for trans-fats.

“ADM is using its expertise to help food manufacturers meet consumers’ demands for variety, taste and health,” saidPaul B. Mulhollem, ADM president and CEO. “The NovaLipid portfolio includes naturally stable oils, tropical oils, blended oils, and enzyme interesterified shortenings and margarines to provide alternatives in various food applications including baking, confectionery, snack, frying and cereal products.”